<p>Pediatrix Medical Group, Inc.（纽约证券交易所代码：MD - 获取免费报告）董事 Laura Linynsky 于 11 月 6 日星期四出售了 10,000 股公司的股票。该股票的平均售价为 21.65 美元，总价值为 216,500.00 美元。出售后，该董事在公司持有 32,232 股，估值约为 697,822.80 美元。此次交易使其持股减少了 23.68%。该交易已在向美国证券交易委员会（SEC）提交的文件中披露，相关文件可通过 SEC 网站访问。</p>
<h2>Pediatrix Medical Group 股价上涨 3.0%</h2>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p>MD 的股票在周一的午盘交易中上涨了 0.66 美元，达到了 22.59 美元。该股票的交易量为 1,259,182 股，而其平均交易量为 777,751 股。该公司 50 日简单移动平均线为 17.29 美元，200 日简单移动平均线为 15.16 美元。该公司的市值为 19.4 亿美元，市盈率为 17.51，贝塔值为 1.20。公司当前比率为 1.80，速动比率为 1.80，债务与股本比率为 0.70。Pediatrix Medical Group, Inc.的 52 周最低价为 11.84 美元，52 周最高价为 22.60 美元。</p>
<p>Pediatrix Medical Group（纽约证券交易所代码：MD - 获取免费报告）最近于 11 月 3 日星期一发布了季度财报。公司报告本季度每股收益为 0.67 美元，超出市场共识预期的 0.46 美元，超出幅度为 0.21 美元。Pediatrix Medical Group 的净利润率为 5.66%，股本回报率为 18.94%。该公司本季度的收入为 4.9288 亿美元，而市场共识预期为 4.7645 亿美元。去年同期，该公司每股收益为 0.44 美元。该公司的季度收入同比下降了 3.6%。分析师预计 Pediatrix Medical Group, Inc.今年的每股收益将达到 1.38 美元。</p>
<h2>分析师评级变动</h2>
<ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
<p>多家券商最近对 MD 发表了看法。Leerink Partners 将 Pediatrix Medical Group 的目标价从 14.50 美元上调至 17.00 美元，并在 9 月 5 日的报告中给予该公司 “市场表现” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Pediatrix Medical Group 股票的 “持有（c）” 评级。Truist Financial 在周一的研究报告中将 Pediatrix Medical Group 的目标价从 17.00 美元上调至 24.00 美元，并给予该公司 “持有” 评级。UBS Group 在 11 月 5 日的研究报告中将 Pediatrix Medical Group 的目标价从 16.50 美元上调至 23.00 美元，并给予该股票 “中性” 评级。最后，Wall Street Zen 在 10 月 4 日的报告中将 Pediatrix Medical Group 的股票评级从 “买入” 上调至 “强力买入”。一位分析师对该股票给予了买入评级，六位分析师对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，平均目标价为 19.80 美元。</p>
<p><strong>查看我们对 MD 的最新分析</strong></p>
<h2>机构投资者对 Pediatrix Medical Group 的看法</h2>
<ul>
<li>5 只未来自动化的机器人股票值得购买</li>
</ul>
<p>几家大型投资者最近对 MD 的持仓进行了调整。Marshall &amp; Sullivan Inc. WA 在第二季度购买了 Pediatrix Medical Group 的新头寸，价值约为 41,000 美元。加拿大养老计划投资委员会在第二季度收购了 Pediatrix Medical Group 的股份，价值 83,000 美元。AlphaQuest LLC 在第一季度将其在 Pediatrix Medical Group 的持股增加了 16.0%。AlphaQuest LLC 现在持有 5,877 股该公司的股票，价值 85,000 美元，此前在上个季度又购买了 811 股。Quantbot Technologies LP 在第二季度收购了 Pediatrix Medical Group 的新股份，价值 99,000 美元。最后，Smartleaf Asset Management LLC 在第三季度将其在 Pediatrix Medical Group 的股份增加了 10.6%。Smartleaf Asset Management LLC 现在持有 6,250 股该公司的股票，价值 101,000 美元，此前在上个季度又购买了 601 股。机构投资者持有该公司 97.71% 的股票。</p>
<h2>Pediatrix Medical Group 公司简介</h2>
<p>（获取免费报告）</p>
<p>Pediatrix Medical Group, Inc.及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专业护理服务。它提供新生儿护理服务，包括通过新生儿医生专业人员、新生儿护士执业者和其他儿科临床医生为早产或有并发症的婴儿提供临床护理。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Pediatrix Medical Group</li>
<li>医疗保健股票解析：为什么你可能想要投资</li>
<li>股价下跌，目标价上升：3 只在上涨超过 10% 后被升级的股票</li>
<li>股息捕捉策略：你需要知道的事项</li>
<li>核能股票正在崩溃——投资者应该恐慌吗？</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>Monday.com 因疯狂抛售而开启了世代机会</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Pediatrix Medical Group 吗？</h2>
<p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Pediatrix Medical Group 并不在名单上。</p>
<p>尽管 Pediatrix Medical Group 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

<p>Pediatrix Medical Group 的董事 Laura Linynsky 出售了 10,000 股，平均价格为 21.65 美元，总计 216,500 美元，代表其持股减少了 23.68%。出售后，她持有 32,232 股，价值约为 697,822.80 美元。该交易已向美国证券交易委员会（SEC）披露。该股票最近上涨 3.0%，至 22.59 美元，市值为 19.4 亿美元，市盈率为 17.51。分析师的评级不一，平均目标价格为 19.80 美元，普遍评级为 “持有”</p>

<p>Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) Director Laura Linynsky sold 10,000 shares of the business's stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $21.65, for a total value of $216,500.00. Following the sale, the director owned 32,232 shares in the company, valued at approximately $697,822.80. The trade was a 23.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc.（纽约证券交易所代码：MD - 获取免费报告）董事 Laura Linynsky 于 11 月 6 日星期四出售了 10,000 股公司的股票。该股票的平均售价为 21.65 美元，总价值为 216,500.00 美元。出售后，该董事在公司持有 32,232 股，估值约为 697,822.80 美元。此次交易使其持股减少了 23.68%。该交易已在向美国证券交易委员会（SEC）提交的文件中披露，相关文件可通过 SEC 网站访问。</p>
</div><h2>Pediatrix Medical Group Trading Up 3.0%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股价上涨 3.0%</h2>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p>Shares of MD traded up $0.66 during midday trading on Monday, hitting $22.59. The stock had a trading volume of 1,259,182 shares, compared to its average volume of 777,751. The business has a 50-day simple moving average of $17.29 and a two-hundred day simple moving average of $15.16. The firm has a market cap of $1.94 billion, a P/E ratio of 17.51 and a beta of 1.20. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $22.60.</p>
<div class="lb-trans"><p>MD 的股票在周一的午盘交易中上涨了 0.66 美元，达到了 22.59 美元。该股票的交易量为 1,259,182 股，而其平均交易量为 777,751 股。该公司 50 日简单移动平均线为 17.29 美元，200 日简单移动平均线为 15.16 美元。该公司的市值为 19.4 亿美元，市盈率为 17.51，贝塔值为 1.20。公司当前比率为 1.80，速动比率为 1.80，债务与股本比率为 0.70。Pediatrix Medical Group, Inc.的 52 周最低价为 11.84 美元，52 周最高价为 22.60 美元。</p>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.46 by $0.21. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $492.88 million during the quarter, compared to the consensus estimate of $476.45 million. During the same quarter in the prior year, the firm earned $0.44 EPS. The firm's quarterly revenue was down 3.6% on a year-over-year basis. As a group, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group（纽约证券交易所代码：MD - 获取免费报告）最近于 11 月 3 日星期一发布了季度财报。公司报告本季度每股收益为 0.67 美元，超出市场共识预期的 0.46 美元，超出幅度为 0.21 美元。Pediatrix Medical Group 的净利润率为 5.66%，股本回报率为 18.94%。该公司本季度的收入为 4.9288 亿美元，而市场共识预期为 4.7645 亿美元。去年同期，该公司每股收益为 0.44 美元。该公司的季度收入同比下降了 3.6%。分析师预计 Pediatrix Medical Group, Inc.今年的每股收益将达到 1.38 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
</div><p>A number of brokerages have recently weighed in on MD. Leerink Partners lifted their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a &#34;market perform&#34; rating in a report on Friday, September 5th. Weiss Ratings restated a &#34;hold (c)&#34; rating on shares of Pediatrix Medical Group in a research report on Wednesday, October 8th. Truist Financial lifted their target price on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a &#34;hold&#34; rating in a research note on Monday. UBS Group increased their price target on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday, November 5th. Finally, Wall Street Zen upgraded shares of Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, October 4th. One analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Hold&#34; and an average target price of $19.80.</p>
<div class="lb-trans"><p>多家券商最近对 MD 发表了看法。Leerink Partners 将 Pediatrix Medical Group 的目标价从 14.50 美元上调至 17.00 美元，并在 9 月 5 日的报告中给予该公司 “市场表现” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Pediatrix Medical Group 股票的 “持有（c）” 评级。Truist Financial 在周一的研究报告中将 Pediatrix Medical Group 的目标价从 17.00 美元上调至 24.00 美元，并给予该公司 “持有” 评级。UBS Group 在 11 月 5 日的研究报告中将 Pediatrix Medical Group 的目标价从 16.50 美元上调至 23.00 美元，并给予该股票 “中性” 评级。最后，Wall Street Zen 在 10 月 4 日的报告中将 Pediatrix Medical Group 的股票评级从 “买入” 上调至 “强力买入”。一位分析师对该股票给予了买入评级，六位分析师对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，平均目标价为 19.80 美元。</p>
</div><p><strong>View Our Latest Analysis on MD</strong></p>
<div class="lb-trans"><p><strong>查看我们对 MD 的最新分析</strong></p>
</div><h2>Institutional Investors Weigh In On Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>机构投资者对 Pediatrix Medical Group 的看法</h2>
</div><ul>
<li>5 Robotics Stocks to Buy for the Future of Automation</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只未来自动化的机器人股票值得购买</li>
</ul>
</div><p>Several large investors have recently made changes to their positions in MD. Marshall &amp; Sullivan Inc. WA bought a new position in Pediatrix Medical Group during the second quarter valued at approximately $41,000. Canada Pension Plan Investment Board acquired a new position in shares of Pediatrix Medical Group during the 2nd quarter worth $83,000. AlphaQuest LLC raised its holdings in shares of Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at $99,000. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Pediatrix Medical Group by 10.6% in the 3rd quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company's stock valued at $101,000 after purchasing an additional 601 shares during the last quarter. Institutional investors own 97.71% of the company's stock.</p>
<div class="lb-trans"><p>几家大型投资者最近对 MD 的持仓进行了调整。Marshall &amp; Sullivan Inc. WA 在第二季度购买了 Pediatrix Medical Group 的新头寸，价值约为 41,000 美元。加拿大养老计划投资委员会在第二季度收购了 Pediatrix Medical Group 的股份，价值 83,000 美元。AlphaQuest LLC 在第一季度将其在 Pediatrix Medical Group 的持股增加了 16.0%。AlphaQuest LLC 现在持有 5,877 股该公司的股票，价值 85,000 美元，此前在上个季度又购买了 811 股。Quantbot Technologies LP 在第二季度收购了 Pediatrix Medical Group 的新股份，价值 99,000 美元。最后，Smartleaf Asset Management LLC 在第三季度将其在 Pediatrix Medical Group 的股份增加了 10.6%。Smartleaf Asset Management LLC 现在持有 6,250 股该公司的股票，价值 101,000 美元，此前在上个季度又购买了 601 股。机构投资者持有该公司 97.71% 的股票。</p>
</div><h2>Pediatrix Medical Group Company Profile</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc.及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专业护理服务。它提供新生儿护理服务，包括通过新生儿医生专业人员、新生儿护士执业者和其他儿科临床医生为早产或有并发症的婴儿提供临床护理。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops</li>
<li>Dividend Capture Strategy: What You Need to Know</li>
<li>Nuclear Stocks Are Melting Down—Should Investors Panic?</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>Monday.com Opens Generational Opportunity With Manic Sell-Off</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Pediatrix Medical Group</li>
<li>医疗保健股票解析：为什么你可能想要投资</li>
<li>股价下跌，目标价上升：3 只在上涨超过 10% 后被升级的股票</li>
<li>股息捕捉策略：你需要知道的事项</li>
<li>核能股票正在崩溃——投资者应该恐慌吗？</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>Monday.com 因疯狂抛售而开启了世代机会</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Pediatrix Medical Group 吗？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Pediatrix Medical Group 并不在名单上。</p>
</div><p>While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Pediatrix Medical Group 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Pediatrix Medical Group（NYSE 代码：MD）的董事 Laura Linynsky 出售了 10,000 股股票